MS Speaks

People with MS seem to get COVID-19 in pretty much the same way as other people--not more or less severely.  But those taking ocrelizumab or rituximab were at significantly greater risk of a more severe case of COVID-19, as were those who had had methylprednisolone less than a month before.

From PubMed (January 24, 2021)--"Disease-modifying therapies and COVID-19 severity in multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/33480077/